SEC Form 4 · accession 0001127602-19-005191
LABCORP HOLDINGS INC. · LH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward T Dodson
Officer — Principal Accounting Officer
Period of report
Feb 7, 2019
Accepted (ET)
Feb 11, 2019 · 7:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 7, 2019 | M | 247 | — | A | 9,512 | D | |
| Common StockF2 | Feb 7, 2019 | F | 68 | $147.46 | D | 9,444 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF5,F1,F4 | — | Feb 7, 2019 | M | 247 | D | — | — | Common Stock | 247 | 1,287 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- F2Amount includes 122.8283 shares acquired on June 29, 2018 and 29.1161 shares acquired on December 31, 2018 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
- F3Stock withholding to satisfy tax withholding obligations.
- F4The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18.
- F5This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
Remarks
Exhibit 24 - Power of Attorney